Introduction {#mjx005s1}
============

The process of morphogenesis/organogenesis involves a complex interplay of growth stimulatory and differentiation signals that direct the formation of functional organs during development. Although initially concealed on some genetic backgrounds, the role of p53 in vertebrate development is now indisputable. Mice with germline *p53* deletion exhibit defects in kidney development, neural tube closure, spermatogenesis, and ocular abnormalities among other defects ([@mjx005C2]; [@mjx005C37]; [@mjx005C39]; [@mjx005C31]). Besides controlling genes in cell cycle and apoptosis pathways, p53 also regulates cell migration, energy metabolism, differentiation, and renewal ([@mjx005C28]; [@mjx005C13]; [@mjx005C21]; [@mjx005C27]; [@mjx005C31]; [@mjx005C41]; [@mjx005C18]). Stimulation of apoptosis and cell cycle arrest by p53 emphasizes the need for tight control of p53 activity during development, highlighting the critical role of Mdm2 and Mdm4 (also known as MdmX) in the negative regulation of p53 function. This was revealed by mouse models of either *Mdm2* or *Mdm4* germline deletion that were embryonic lethal in a p53-dependent manner ([@mjx005C11]; [@mjx005C34]). The oncogenic nature of Mdm2/Mdm4 was recognized from their overexpression observed in several human cancers, thereby subduing wild-type p53 activity and consequently transforming cells ([@mjx005C5]; [@mjx005C36]; [@mjx005C44]; [@mjx005C23]). Increased p53 expression also impacts organogenesis, as evidenced in transgenic mice overexpressing p53 in the ureteric bud (UB) lineage of the developing kidney ([@mjx005C15]). These mice have nephron deficiency, renal hypoplasia, and altered differentiation of the ureteric epithelium. Unabated p53 activity from conditional *Mdm2* and/or *Mdm4* deletion results in defects in lens and skeletal morphogenesis ([@mjx005C22]; [@mjx005C46]), and impaired nephrogenesis as discussed in this review.

Kidney development {#mjx005s2}
==================

The mammalian kidney develops via inductive signalling between three cell lineages that derive from the intermediate mesoderm at embryonic day E8.5 in the mouse and gestational weeks 4--5 in humans. The nephric or Wollfian duct gives rise to the UB that via reiterative branching and elongation arborizes to form the collecting duct system (Figure [1](#mjx005F1){ref-type="fig"}A); the metanephric mesenchyme (MM) gives rise to all segments of the nephron; and the stroma, surrounding the UB and cap mesenchyme (CM), gives rise to the vasculature, glomerular mesangial cells, and renin-forming cells (Figure [1](#mjx005F1){ref-type="fig"}A) ([@mjx005C9]; [@mjx005C26]). The cells of the MM condense around the UB tip to form the CM that houses the nephron progenitor cells (NPC) (Figure [1](#mjx005F1){ref-type="fig"}A). NPC availability by self-renewal during embryonic development is a critical driver of nephron endowment at birth. Kidney function is directly proportional to functional nephron number. Low nephron endowment at birth is strongly associated with the development of cardiovascular diseases in adult life. The NPC express Six2, which maintains the NPC in progenitor state. Loss of Six2 results in precocious differentiation and depletion of the NPC pool, resulting in suboptimal nephron endowment ([@mjx005C42]). Therefore, maintenance of Six2 expression by the NPC is critical for their self-renewal to adequately populate the kidney with nephrons.

![Developmental expression of Mdm2, Mdm4, and p53 in the murine kidney. (**A**) The nephric duct gives rise to the UB that arborizes to form the collecting duct system; the MM gives rise to all segments of the nephron; and the stroma surrounding the UB and CM gives rise to the vasculature, glomerular mesangial cells, and renin-forming cells. The cells of the MM will condense around the UB tips along the periphery to form the CM that houses the NPC. The CM will self-renew, and a subset of the NPC will be induced and undergo differentiation to form nascent nephrons including the PA, RV, and CS, which will mature to functional nephrons. (**B**) Temporal regulation is observed for Mdm2 and p53, with high mRNA expression levels during kidney organogenesis declining 3- and 4-fold, respectively, in neonate kidney and further still by postnatal day P20. This is modified from [@mjx005C39] and [@mjx005C16]. (**C**) Schematic showing spatial distribution of differentially modified p53. P-p53^S392^ is localized in differentiated proximal tubule cells but not in proliferating cells, whereas acetylated p53^K373/K382/K386^ shows predominant localization in the nephrogenic niche that houses UB tips, NPC, and cortical stroma, and also in the distal tubule and the collecting duct. This is modified from [@mjx005C1].](mjx005f01){#mjx005F1}

Wnt9b from the UB maintains the Cited1+/Six2+ NPC in progenitor state, while inducing the Cited1−/Six2+ NPC to undergo differentiation ([@mjx005C7]; [@mjx005C19]). The differentiating NPC are lateral to the UB tip and will form the pretubular aggregate (PA, Figure [1](#mjx005F1){ref-type="fig"}A) before undergoing mesenchyme-to-epithelial transition (MET) that results in the formation of the renal vesicle (RV). The PA expresses Wnt4, Fgf8, Pax8 while decreasing levels of Six2; these cells have exited the progenitor pool ([@mjx005C12]; [@mjx005C14]). The RV expresses epithelial markers ZO1 and E-Cadherin and will progress through nascent nephron structures (CS, comma-shaped body) that gradually mature to functional nephrons ([@mjx005C14]).

Mdm2, Mdm4, and p53 expression in the developing kidney {#mjx005s3}
=======================================================

Mdm2 and Mdm4 mRNA expression expectedly follow the spatial expression pattern of p53, ubiquitous in all the cell lineages of the developing mouse kidney ([@mjx005C39]; [@mjx005C16]). Temporal regulation is observed for Mdm2/Mdm4 and p53, with high mRNA expression levels declining 3- and 4-fold, respectively, in neonate kidney and further still by postnatal day P20 (Figure [1](#mjx005F1){ref-type="fig"}B). Protein levels follow this temporal pattern of transcript expression, with a more pronounced decrease in p53 protein levels in adult kidneys ([@mjx005C1]). In addition to protein stability, functional aspects of p53 activity are regulated by stimuli-specific post-translational modifications ([@mjx005C29]). Interestingly, differentially modified p53 shows spatial distribution, with P-p53^S392^ localized in differentiated proximal tubule cells but not in proliferating cells and acetylated p53^K373/K382/K386^ showing predominant localization in the nephrogenic niche that houses UB tips, NPC, and cortical stroma (Figure [1](#mjx005F1){ref-type="fig"}C) ([@mjx005C1]). This spatio-temporal expression pattern is suggestive of differential context-driven activities for the Mdm2/Mdm4--p53 pathway during nephrogenesis.

Lineage-specific *Mdm2* deletion from the mammalian embryonic kidney {#mjx005s4}
====================================================================

Mdm2 deletion from the ureteric epithelia {#mjx005s4a}
-----------------------------------------

We generated and characterized mice with conditional deletion of *Mdm2* from the ureteric epithelium (UB^*Mdm2−/−*^); these mice display severe renal hypodysplasia and die soon after birth ([@mjx005C16]). The kidneys show defective UB branching and a marked decrease in UB tips. Although UB^*Mdm2−/−*^ cells showed reduced proliferation rate and 3-fold higher apoptosis, two markers of UB tip identity, *c-Ret* and *Wnt11*, continue to be expressed. The nephrogenic zone is underdeveloped with decrease in Wnt signalling from the ureteric epithelium, as a result of decreased Wnt9b expression. Wnt signalling is essential for all aspects of kidney development. Accordingly, the disruption of UB−CM crosstalk secondary to the branching morphogenesis defect results in a disorganized CM and impaired nephron formation. Elimination of both *p53* alleles restored normal branching of the UB as well as the nephron deficit and postnatal survival, whereas one-allele *p53* deletion produced only a partial rescue of the phenotype. *Mdm4* deletion from the ureteric epithelium also results in UB branching defects, renal hypoplasia, and nephron deficit, but does not result in perinatal death, and the extent of apoptosis and proliferation defects is much less severe than that from *Mdm2* gene deletion (our unpublished data). Double deletion of *Mdm2* and *Mdm4* from the UB, however, resulted in severe renal hypoplasia (Figure [2](#mjx005F2){ref-type="fig"}A). Most double mutants die perinataly. Hematoxylin and eosin (H&E) staining shows severely dysmorphic kidneys (our unpublished data).

![Lineage-specific *Mdm2*, *Mdm4*, or *p53* deletion from the mammalian embryonic kidney. (**A**) Severe renal hypoplasia with double deletion of *Mdm2* and *Mdm4* from the UB. Most double mutants die perinataly. H&E staining shows severely dysmorphic kidneys (our unpublished data). P3, postnatal day 3. (**B**) E14.5 NPC^*Mdm2−/−*^ mutant kidneys are hypodysplastic with a markedly thinner CM and fewer Six2+ cells (red). E-cadherin (green) marks the epithelial structures. This is modified from [@mjx005C17]. (**C**) Immunofluorescent staining with CM marker Six2 (red) demonstrates a diminished CM in NPC^*p53−/−*^ mutant kidneys at E13.5. BrdU-labelling of proliferating cells in the CM shows decreased BrdU incorporation (green) in the p53-mutant CM. This is modified from [@mjx005C24].](mjx005f02){#mjx005F2}

Mdm2 deletion from NPC {#mjx005s4b}
----------------------

Our laboratory generated and characterized mice with conditional deletion of *Mdm2* in the Six2+ NPC (NPC^*Mdm2−/−*^), which also results in perinatal lethality ([@mjx005C17]). The mutant kidneys are hypodysplastic. The CM is markedly thinner with fewer self-renewing Cited1+/Six2+ cells (Figure [2](#mjx005F2){ref-type="fig"}B) ([@mjx005C17]) and greatly reduced or lost progenitor markers such as Amphiphysin, Sall1, Pax2, *Eya1*, and *Bmp7*, whereas expression of differentiation markers *Wnt4*, *Lhx1*, and *Pax8* is unchanged. Increased p53 levels drive increased apoptosis and reduced proliferation observed in the NPC^*Mdm*2*−/−*^, along with reduced renal parenchyma and increased stroma. As with the germline and UB^*Mdm2−/−*^ mutants, *p53* deletion rescued the progenitor cell depletion and hypodysplasia and restored normal renal development and postnatal survival of mice ([@mjx005C17]). These results demonstrate a critical and cell autonomous role for Mdm2 in the UB and MM lineages. Mdm2-mediated inhibition of p53 activity is a prerequisite for renal organogenesis and plays an essential role in the renewal and survival of NPC. Loss of functional Mdm2 results in stable, constitutively active p53 that is responsible for elevated apoptosis and premature depletion of the Six2+ cap cells.

Rescue of the kidney phenotype from *Mdm2* deletion by co-deletion of *p53* indicates that the renal phenotype is largely p53-dependent, and that the effects of p53 are dominant ([@mjx005C16]). However, this does not mean that Mdm2/Mdm4 do not have p53-independent actions. Elevated Mdm2/Mdm4 levels are associated with genomic instability independent of p53 ([@mjx005C4]; [@mjx005C6]). Recent studies demonstrate that Mdm2 interacts with enhancer of zeste homologue 2 (EZH2), a member of the Polycomb Repressive Complex 2 (PRC2), to promote trimethylation at histone H3 lysine 27 (H3K27me3) and ubiquitination at histone 2A lysine 119 (H2AK119). This interaction promotes stemness in mesenchymal stem cells by supporting PRC2-driven repression of lineage-specific genes ([@mjx005C45]). Whether any of the above-mentioned p53-independent actions of Mdm2/Mdm4 occurs during kidney development is under investigation.

*p53* deletion from the mammalian embryonic kidney {#mjx005s5}
==================================================

A variety of developmental defects of the kidney and urinary tract are observed with germline *p53* deletion in mice on a C57BL6 background, most frequently double ureters and renal hypoplasia (Table [1](#mjx005TB1){ref-type="table"}) ([@mjx005C38], [@mjx005C39]). The *p53*^*−/−*^ embryo at E11.5 has a smaller MM, observed by whole mount immunofluorescence with Pax2 antibody (our unpublished data). All mouse models of *p53* gene deletion on B6SJL and FVB mixed backgrounds showed hypoplasia, whereas duplex ureters were only observed when p53 function was deleted or impaired in the nephric duct/UB lineage (Table [1](#mjx005TB1){ref-type="table"}) ([@mjx005C39]; [@mjx005C24]). Table 1Comparison of phenotypes after *p53*, *Mdm2*, or *Mdm4* deletion.Modelp53Mdm2Mdm4GermlineViableEmbryonic lethal ([@mjx005C11])Embryonic lethal ([@mjx005C34])Duplex, nephron deficit, hypoplasia ([@mjx005C39])Deletion in UBViableNeonatal lethalDie postnatally around weaning ageDuplex, hypoplasia ([@mjx005C39])Branching defects, hypoplasia, nephron deficit, high apoptosis in UB ([@mjx005C16])Branching defects, hypoplasia, nephron deficit, high apoptosis in UB (our unpublished data)Rescued by *p53* gene deletion ([@mjx005C16])Deletion in CMNPC loss, apoptosis not increased, longer cell cycle, hypoplasia, nephron deficit, stroma expansion ([@mjx005C24])NPC loss, increased apoptosis, nephron deficit, stromal expansion, perinatal death ([@mjx005C17])Not done

p53 loss in the nephric duct lineage {#mjx005s5a}
------------------------------------

That p53 antagonizes the glial cell line-derived neurotrophic factor (GDNF)→c-Ret→phosphatidylinositol-3 kinase (PI3K) pathway was demonstrated by siRNA-mediated p53 inactivation in UB cells. The enhanced PI3K activation by GDNF was measured by the increase in phospho-Akt levels ([@mjx005C39]). As p53-null nephric ducts (ND^*p53−/−*^) do not exhibit increased cell proliferation, other Akt-mediated pathways such as cell migration may contribute to the duplex phenotype. The underlying mechanisms for ND^*p53−/−*^ hypersensitivity to GDNF remain to be elucidated. Whether this increased sensitivity also extends to other growth factors such as fibroblast growth factors (FGFs) is not known. While other models of UB ectopia exhibit increased receptor tyrosine kinase (RTK) signalling resulting either from decreased levels of the RTK signalling antagonist Sprouty-1 (Spry1) or an expanded GDNF domain, these were unchanged in p53-null models ([@mjx005C39]). Chimera experiments with GFP-labelled p53-null cells in the UB lineage revealed neither a preponderance nor exclusion of mutant cells at the leading edge of the UB or tips (our unpublished data). An attractive possibility that remains to be tested is that p53 and phospho-Smad cooperate to inhibit ectopic budding in the nephric duct by activating a cytostatic pathway, given that heterozygous deletion of *Bmp4* results in duplex ureters ([@mjx005C30]). Alternatively, modulation of regulators of heparin sulphate such as heparanase and extracellular heparin sulphate 6-O-endosulfatases, which are known p53 targets, may deregulate heparin sulphate proteoglycans that control effective growth factor (GDNF, FGFs, BMPs) concentrations in a microenvironment, thereby contributing to ectopic signalling and bud formation ([@mjx005C3]; [@mjx005C8]; [@mjx005C43]). Also, the involvement of other factors such as modifier genes ([@mjx005C33]) cannot be discounted in regulating UB induction.

p53 loss in the MM {#mjx005s5b}
------------------

We recently reported that conditional deletion of *p53* from the MM using a Six2Cre driver results in kidney hypoplasia with a sparse, less compact, and disorganized E13.5 CM (Figure [2](#mjx005F2){ref-type="fig"}C) ([@mjx005C24]). A clear deficit of differentiating nephrons is observed in P0 kidney sections. Glomerular dysfunction is indicated in PAS-stained kidneys displaying proteinaceous or hyaline material in Bowman\'s space. As Cited1 marks the self-renewing population, the progressive loss of Cited1+/Six2+ cells suggests a decreased capacity for self-renewal. Quantitatively, Six2^*p53−/−*^ kidneys have 30% less Six2+ cells. Neural cell adhesion molecule (NCAM1), present at intercellular domains of CM and nascent nephrons, is greatly decreased in the mutant CM ([@mjx005C24]). NCAM1 is required for cell--cell and cell--matrix interactions during development and differentiation. Reduced Pax2 staining was reported in both germline and conditional Six2^*p53−/−*^ kidneys. *In vivo* and *in vitro* reporter analyses demonstrated that *Pax2* is a p53 target gene ([@mjx005C40]), implicating p53 in regulating the expression of a key kidney development protein. Although the remaining Six2+(p53-null) cells are capable of differentiating into nascent nephrons, this does not alleviate the pronounced nephron deficit observed in mutant kidneys in embryonic and P0 kidney sections. Induction of the Wnt/β-catenin pathway to induce MET in an *in vitro* assay on isolated Six2+ CM cells revealed a differentiation defect in p53-null cells ([@mjx005C24]). The mutant cells were unable to form complex structures observed in wild-type cells, and show decreased conversion to epithelia as determined by E-cadherin staining. *Fgf8* expression (typically observed in the PA/RV, see Figure [1](#mjx005F1){ref-type="fig"}) is greatly diminished in the Six2^*p53−/−*^ kidneys. However, expression of differentiation genes *Pax8* and *Wnt4* did not show a marked change. Treatment of Six2^*p53−/−*^ kidneys *ex vivo* with Fgf8 beads did not demonstrate any localized rescue of MET, indicative of additional epithelialization defects in the p53-null CM. Thus, the nephron deficit in Six2^*p53−/−*^ kidneys is a result of at least two developmental defects: (i) self-renewal defect of Cited1+/Six2+ NPC resulting in reduced availability of progenitors for nephrogenesis, and (ii) improper differentiation from an inefficient response to Wnt/β-catenin signalling, or defective MET, or both in Six2+(p53-null) cells (Figure [2](#mjx005F2){ref-type="fig"}C) ([@mjx005C24]).

p53 regulates energy metabolism in nephron progenitors {#mjx005s5c}
------------------------------------------------------

No increase in either apoptosis or senescence was observed in Six2^*p53−/−*^ cells, examined by PARP or active caspase-3 and senescence marker SA-βgal staining, respectively ([@mjx005C24]). Moreover, γH2Ax staining---a gauge of DNA damage---was also not increased, indicating that p53 is not exclusively involved in maintenance of genomic stability in the developing kidney. Unexpectedly, after p53 loss, the proliferation index of the CM is significantly lower compared to wild-type CM at E15.5. Cell cycle analysis revealed that more Six2^*p53−/−*^ cells are in G0/G1, and a significantly smaller fraction are in S and G2/M. Contrary to expectations, transcriptome profiling by RNA-seq of Six2^*p53−/−*^ NPC surprisingly showed decreased, rather than increased, levels of transcripts of cell cycle inhibitors p21 (*Cdkn1a*) and p57 (*Cdkn1c*), indicative of an alternate explanation for decreased proliferation ([@mjx005C24]).

Our studies using ChIP-seq showed that p53 chromatin occupancy was detected on diverse genes in the developing kidney beyond the canonical p53 targets ([@mjx005C25]). Transcription analysis showed dysregulation of genes beyond the classical pathways associated with p53 regulation, including development and morphology, cell adhesion and migration, cell survival, metabolism, and ion transport ([@mjx005C24]). Expression of multiple genes in cell adhesion and migration pathways is decreased, phenotypically observed by the loosely organized CM in Six2^*p53−/−*^ kidneys. Disruption of biophysical and biomechanical cues from the extracellular matrix to cells within the niche can be envisioned to influence renewal and differentiation programmes ([@mjx005C10]).

We found that genes involved in glucose metabolism, the pentose phosphate pathway, and the electron transport chain or genes required to maintain a proton gradient for adenosine triphosphate (ATP) production during oxidative respiration are dysregulated in Six2^*p53−/−*^ cells ([@mjx005C24]). These are among the most regulated genes and include phosphoenol pyruvate carboxykinase 1 (*Pck1*, −14.3-fold), cytochrome P450 2D26 (*Cyp2d26*, −13.0-fold), fructose bisphosphatase 1 (*Fbp1*, \~12.0-fold), and aldolase b (*Aldob*, −12.1-fold). Moreover, functional analyses showed decreased reactive oxygen species (ROS) and ATP levels in Six2^*p53−/−*^ cells, indicative of mitochondrial dysfunction. Thus, it appears that the p53-deficient NPC undergo deregulation of metabolic homoeostasis that compromises the metabolic fitness of the Cited1+/Six2+ NPC, thereby impeding their self-renewal. It needs to be emphasized, however, that decreases in ATP (and ROS) are not the only outcomes of deregulated energy metabolism that impact cell fate. Alterations in energy pathways result in changes in metabolites as well (e.g. Acetyl-CoA), which are key regulators of epigenetic modifications that control gene expression ([@mjx005C20]; [@mjx005C32]).

Surprisingly, a consistent observation in all the models studied has been the decrease in cell proliferation with p53 loss ([@mjx005C39], [@mjx005C40]; [@mjx005C24]), suggesting that p53 mediates more divergent pathways in kidney development than in cancer. This idea is further supported upon comparison of p53 occupancy on chromatin from embryonic kidneys and cancer-derived cell lines ([@mjx005C25]). Not only is the pattern of chromatin occupancy different between embryonic kidney and cancer cells (promoter versus non-promoter/intergenic regions, respectively), but also the number and variety of genes that are enriched vary. p53 gene occupancy in embryonic kidneys extends beyond cell cycle and apoptosis genes---expected in cells with genotoxic stress-induced p53---in development and morphology, chromatin modifying enzymes, and genes in metabolic pathways ([@mjx005C25]).

Distinct mechanisms of UB branching and nephrogenesis defects in kidneys with Mdm2/Mdm4 or p53 loss {#mjx005s6}
===================================================================================================

UB-specific *Mdm2* deletion results in a hypoplastic UB and subsequent defects in branching and nephrogenesis, whereas deletion of *p53* from the UB results in duplex ureters in a third of the animals, as well as UB hypoplasia and branching defects (depicted in Figure [3](#mjx005F3){ref-type="fig"}A) ([@mjx005C39]; [@mjx005C16]). Loss of Mdm2 or p53 resulted in NPC depletion. Thus, while the final outcome from both mutant models is nephron deficit and renal hypoplasia (depicted in Figure [3](#mjx005F3){ref-type="fig"}B), the mechanisms leading to this phenotype are quite different in each case as outlined in Figure [3](#mjx005F3){ref-type="fig"}C. Whereas p53 loss decreases NPC self-renewal possibly from disrupted cellular metabolism and adhesion, p53 overexpression via *Mdm2* deletion causes NPC depletion by decreasing proliferation and increasing apoptosis ([@mjx005C17]; [@mjx005C24]). UB^*Mdm4−/−*^ kidney microarray implicates repression of differentiation pathways and alterations in metabolic pathways as well (our unpublished data).

![Schematic comparison of kidney phenotypes after *Mdm2* or *p53* conditional deletion from UB or CM lineage. (**A**) UB-specific *Mdm2* deletion results in a hypoplastic UB and subsequent defects in branching and nephrogenesis. Deletion of *p53* from the UB results in duplex ureters in a third of the animals, as well as UB hypoplasia and branching defects. Final outcome from both mutant models is nephron deficit and renal hypoplasia. This is adapted from [@mjx005C39] and [@mjx005C16]. (**B**) Conditional deletion of *Mdm2* or *p53* from the MM using a Six2Cre driver results in kidney hypoplasia with a sparse, disorganized CM. A marked paucity of differentiating nephrons is observed in P0 kidneys. Cortical stroma (dark grey) is expanded in both cases. This is adapted from [@mjx005C17] and [@mjx005C24]. (**C**) Distinct mechanisms of nephron deficit in kidneys with Mdm2 or p53 loss. While loss of either protein results in NPC depletion, the mechanisms leading to this phenotype are quite different in each case. Whereas p53 loss decreases NPC self-renewal possibly from disrupted cellular metabolism and adhesion, *Mdm2* deletion causes NPC depletion by decreasing proliferation and increasing apoptosis.](mjx005f03){#mjx005F3}

Future perspectives {#mjx005s7}
===================

Conditional loss of either p53, Mdm2, or Mdm4 hinders mouse kidney development, with Mdm2/Mdm4 loss resulting in a fatal outcome from severe renal dysgenesis ([@mjx005C39]; [@mjx005C16]; [@mjx005C17]; ; [@mjx005C24]). Thus, control of the Mdm2/Mdm4−p53 nexus is crucial for proper kidney development and to achieve a full complement of nephrons. While mutations in *Mdm2/Mdm4/p53* genes have yet to be identified in infants and children with congenital renal dysgenesis, it is also clear that adverse intra-uterine environmental conditions upregulate p53 activity in the developing kidney and are associated with impaired nephrogenesis ([@mjx005C35]). Accordingly, future studies should examine how gene−environment interactions shape nephron endowment via the Mdm2/Mdm4−p53 axis. Another area of fruitful investigation will be investigating non-canonical roles of p53 and Mdm2/Mdm4, as this will provide a more comprehensive view of their developmental functions that may be applicable to their roles in cancer.
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